Exponent (NASDAQ:EXPO) VP Shukri Jeries Souri Acquires 184 Shares of Stock

Posted by Geri Gentry on Sep 23rd, 2026

Exponent, Inc. (NASDAQ:EXPO – Get Free Report) VP Shukri Souri acquired 184 shares of the firm’s stock in a transaction dated Friday, September 18th. The shares were bought at an average cost of $68.45 per share, with a total value of $12,594.80. Following the completion of the acquisition, the vice president directly owned 40,873 shares of the company’s stock, valued at $2,797,756.85. The trade was a 0.45% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.

Exponent Trading Down 1.3%

Shares of EXPO stock opened at $66.22 on Wednesday. The stock has a market capitalization of $3.15 billion, a P/E ratio of 29.70 and a beta of 0.68. The firm’s 50 day moving average is $67.08 and its 200 day moving average is $64.14. Exponent, Inc. has a 12-month low of $51.91 and a 12-month high of $81.95.

Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The business services provider reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.05. Exponent had a return on equity of 31.48% and a net margin of 17.67%.The firm had revenue of $171.61 million for the quarter, compared to analysts’ expectations of $144.99 million. During the same period in the prior year, the firm earned $0.52 EPS. The company’s revenue was up 12.0% compared to the same quarter last year. As a group, equities analysts predict that Exponent, Inc. will post 2.31 earnings per share for the current year.

Exponent Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 18th. Shareholders of record on Friday, September 4th were given a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Friday, September 4th. Exponent’s dividend payout ratio (DPR) is presently 55.61%.

Institutional Investors Weigh In On Exponent

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Quantinno Capital Management LP boosted its position in shares of Exponent by 114.3% in the first quarter. Quantinno Capital Management LP now owns 36,614 shares of the business services provider’s stock worth $2,389,000 after purchasing an additional 19,528 shares during the period. Royce & Associates LP increased its stake in shares of Exponent by 73.8% in the fourth quarter. Royce & Associates LP now owns 652,109 shares of the business services provider’s stock worth $45,295,000 after purchasing an additional 276,889 shares in the last quarter. New Age Alpha Advisors LLC raised its position in shares of Exponent by 785.8% during the 4th quarter. New Age Alpha Advisors LLC now owns 24,775 shares of the business services provider’s stock valued at $1,721,000 after purchasing an additional 21,978 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Exponent by 2.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 918,885 shares of the business services provider’s stock valued at $59,958,000 after purchasing an additional 20,270 shares during the period. Finally, Renaissance Technologies LLC purchased a new position in shares of Exponent during the 1st quarter valued at $5,742,000. 92.37% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on EXPO shares. JPMorgan Chase & Co. upped their price target on shares of Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. UBS Group set a $72.00 target price on shares of Exponent and gave the company a “neutral” rating in a research report on Friday, July 31st. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a report on Friday, July 17th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, Exponent has an average rating of “Moderate Buy” and an average target price of $81.00.

Get Our Latest Stock Analysis on EXPO

Exponent Company Profile

(Get Free Report)

Exponent, Inc is a multidisciplinary engineering and scientific consulting company that helps clients investigate complex technical issues, manage risk and improve the safety, performance and reliability of products, systems and operations. Its work commonly involves failure analysis, accident reconstruction, product liability, materials and structures, biomechanics, environmental sciences and health, and human factors.

The company provides consulting, testing, research and expert-witness services to businesses, insurers, law firms and government agencies.